Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Long-Term Investments (2021 - 2022)

Historic Long-Term Investments for Biote (BTMD) over the last 2 years, with Q1 2022 value amounting to $317.6 million.

  • Biote's Long-Term Investments rose 2.14% to $317.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $317.6 million, marking a year-over-year increase of 2.14%. This contributed to the annual value of $317.6 million for FY2021, which is N/A changed from last year.
  • As of Q1 2022, Biote's Long-Term Investments stood at $317.6 million, which was up 2.14% from $317.6 million recorded in Q4 2021.
  • Biote's Long-Term Investments' 5-year high stood at $317.6 million during Q1 2022, with a 5-year trough of $317.5 million in Q2 2021.